A new antimitotic substance, FR182877. II. The mechanism of action.
Sato
B
B
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan.
Nakajima
H
H
Hori
Y
Y
Hino
M
M
Hashimoto
S
S
Terano
H
H
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D009391:Nephelometry and Turbidimetry / Q000379:methods; D011083:Polycyclic Compounds / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; C408303:FR 182877; D011083:Polycyclic Compounds